JPMorgan Resets UnitedHealth Stock Target for 2026
JPMorgan analyst has reset the price target for UnitedHealth (UNH) for 2026, following a severe correction from its all-time closing high of $603.20 in November 2024, when the stock was trading around $300-$312 a year ago. The adjustment comes amid CEO departure and guidance withdrawal.
Key Numbers
A JPMorgan (JPM) analyst has reset the price target for UnitedHealth Group (UNH) for 2026, according to a report from TheStreet. The move follows a sharp downward correction from the stock's all-time closing high of $603.20 in November 2024, with shares trading in the $300-$312 range a year ago.
Recommendation Change
The report did not explicitly state the previous or new price target, but indicated the adjustment comes amid a reassessment of the company after the stock declined roughly 50% from its peak.
Analyst's Rationale
The analyst cited several factors:
- Sudden resignation of CEO Andrew Witty.
- Withdrawal of previous financial guidance.
- Uncertainty in the healthcare sector.
Context
UnitedHealth currently trades well below its historic high, with investor confidence shaken by leadership changes and regulatory challenges. Other analysts remain cautious, with mixed recommendations ranging from sell to hold.
What to Make of It
The JPMorgan price target reset suggests the stock may be undervalued after the sharp correction, but risks persist. Investors should monitor leadership and financial developments closely before making decisions.
Frequently Asked Questions
Found this useful? Share it